Cancel
Celmatix
See Linkedin
Celmatix Employees
11 people indexed:
-
p.4qw@s3gqk53k.s7b Sign up to see email
-
5.8yu6zyrw@g7zj0jwp.251 Sign up to see email
-
Charlotte Frank Sage
Vice President, Clinical Research Operations
z.5djzd.7d39@3h33424d.u9q Sign up to see emailw.7z9y3.8976@wwq23uyw.ydy Sign up to see email -
u.p876yr@j2jp2ygz.gfd Sign up to see email
-
0.z0d@67n8wgsp.wfs Sign up to see email
-
r.bhs@8hb3q345.rwg Sign up to see email
-
1.r67qqu4z@s0n0ykgb.k80 Sign up to see email
-
q.0kjj183.63q7@fw7820q5.jq3 Sign up to see email
-
q.kyk8p58j@vg47v6zw.v8p Sign up to see email
-
s.6.y553k5f@zs791j20.2ju Sign up to see email
-
q.412n6d@f4142zkv.5zf Sign up to see email
Celmatix Company Information
Celmatix is a preclinical-stage biotechnology company that specializes in enhancing women’s health through advanced research in ovarian health. The company has developed the largest structured dataset on ovarian health and outcomes globally, which supports its mission to pioneer the next generation of women’s health therapeutics. Celmatix collaborates with industry leaders, including a significant partnership with Evotec to target conditions such as endometriosis, PCOS, and ovarian senescence. Additionally, it works with Bayer to identify novel PCOS targets and develop new treatments. The company’s research infrastructure includes a discovery program with proprietary cohorts comprising over half a million individuals’ treatment and medical histories, genomic data, and biological samples. Celmatix employs proprietary research tools, such as an annotation platform that integrates all published research in the field, enhanced by NLP neural network models. It also engages in cohort studies through the Personalized Reproductive Medicine initiative alongside fifteen leading reproductive health centers in the United States. Furthermore, Celmatix receives funding support from the Bill & Melinda Gates Foundation for contraceptive discovery and development, focusing on next-generation female contraceptive drug discovery.
Report inaccurate information
Report inaccurate information
